BBH ETF Forecast & Price Targets
BBH Analyst Ratings
Moderate Buy
23Buy1Hold1Sell
Based on the Wall Street analyst consensus for 25 of BBH’s holdings.
BBH 12 Month Forecast
Average Price Target
$271.91▲(5.40% Upside)Based on Wall Street analyst 12-month price targets for 25 of VanEck Biotech ETF’s holdings in the last 3 months. The average price target is $271.91 with a high forecast of $329.46 and a low forecast of $192.82. The average price target represents a 5.40% change from the last price of $257.98.
Past 12 Months12 Month ForecastJan2026Oct2026
High$329.46
Average$271.91
Low$192.82
Highest Price TargetHighest$329.46Average Price Target$271.91Lowest Price TargetLowest$192.82
BBH Stocks With Highest Upside Potential
BBH Stocks With Highest Downside Potential
BBH ETF FAQ
What is BBH’s average 12-month price target, according to analysts?
Based on Wall Street analyst price targets for 25 of BBH’s holdings, VanEck Biotech ETF’s 12-month average price target is $271.91.
What is BBH’s upside potential, based on the analysts’ average price target?
BBH’s average price target of $271.91 represents a 5.40% upside from its last price of $257.98.
Is BBH a Buy, Sell or Hold?
VanEck Biotech ETF has a consensus rating of Moderate Buy, based on the analyst consensus for 25 of BBH’s holdings: 23 rated Buy, 1 rated Hold and 1 rated Sell.
What is VanEck Biotech ETF’s price target?
The average price target for VanEck Biotech ETF is $271.91, based on Wall Street analyst 12-month price targets for 25 of BBH’s holdings, issued in the past 3 months. The highest price target is $329.46 and the lowest is $192.82. The average price target represents a 5.40% increase from the last price of $257.98.
What is BBH’s expense ratio?
BBH’s expense ratio is 0.35%.
How many holdings does BBH have?
BBH holds 26 assets.
How can I buy shares of BBH?
You can buy shares of BBH through a brokerage account. Compare brokers on our Best Online Brokers page.